The performance of a commercial radioligand binding assay for the epidermal growth factor receptor is comparable to the EORTC standard assay

Eur J Cancer. 1995 Sep;31A(10):1710-1. doi: 10.1016/0959-8049(95)00339-k.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Breast Neoplasms / chemistry*
  • ErbB Receptors / analysis*
  • Female
  • Humans
  • Radioligand Assay / methods
  • Radioligand Assay / standards*
  • Reagent Kits, Diagnostic / standards*
  • Reproducibility of Results

Substances

  • Reagent Kits, Diagnostic
  • ErbB Receptors